Saturday, September 09, 2017 1:18:39 PM
https://www.google.com/amp/s/seekingalpha.com/amp/article/4101885-adamas-fda-approval-really-means
But continues to admits----
(ADMS)
it has sufficient cash to fund operations for the next 12 months. There are two things to point out here. The first is that a company with only 12 months of cash left does not wait until the end to raise. Secondly, now that GOCOVRI has been approved it will likely cost a lot of money to launch it.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM